The Effect of Cataract on Photoentrainment of the Circadian Rhythm in Humans
NCT ID: NCT01686308
Last Updated: 2015-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2011-02-28
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this project is to study how the circadian regulating cells of the retina is affected by cataract and by the operation. Cataract patients are studied before and after the operation with questionnaires, hormone and activity measurements and with a specialized pupil measurement that measures the indirect response of the circadian regulating cells to blue light.
Results from this study aim to shed light on the regulatory mechanisms of the eye on the circadian rhythm and how these are affected by cataract. Furthermore, choice of intraocular lens is evaluated. This may have impact on clinical practise especially with regard to choice of intraocular lens and widened indications for cataract surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Refractive Results and Patient Satisfaction After Cataract Surgery
NCT05001932
The Application of Lens Dysfunction Index (DLI) in the Timing of Age-related Cataract Surgery
NCT04711395
Spherical Aberration and Contrast Sensitivity Function in Eyes Implanted With Spherical and Aspheric Intraocular Lenses: A Clinical Trial
NCT01028872
A Pilot Study Investigating the Impact of Different IOL Designs on Subjective 2D and 3D Image Quality
NCT02409641
Improving Vision and Quality of Life in the Nursing Home
NCT00347620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional Intra Ocular Lens (IOL)
Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.
Conventional Intra Ocular Lens (IOL)
Standard operation with conventional IOL implantation
Yellow Intra Ocular Lens (IOL)
Standard minimal incision cataract surgery by phacoemulsification and posterior intraocular lens implantation.
Yellow Intra Ocular Lens (IOL)
Standard operation with blue light filter Yellow IOL implantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yellow Intra Ocular Lens (IOL)
Standard operation with blue light filter Yellow IOL implantation
Conventional Intra Ocular Lens (IOL)
Standard operation with conventional IOL implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eligible for phaco-emulsification on both eyes
Exclusion Criteria
* Known systemic disease, which may affect the retina (untreated hypertension, DM etc.)
* Known systemic disease, which may affect the lens.
* Known psychiatric disease.
* Known sleep or circadian rhythm disorder, not caused by lowered blue light transmission by the lens.
* Per- and post operative complications
* Use of drugs that may affect the sleep.
For a subpopulation also:
* Poor cooperation.
* Severe refraction abnormalities.
* Previous eye surgery
* Nystagmus
* Congenital or acquired abnormalities of: eye lids and eye area, cornea or iris.
* Use of medicine that may affect the pupillary response.
* Use of drugs that may affect the pupillary response.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glostrup University Hospital, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adam Elias Brøndsted
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam E Brøndsted, MD
Role: PRINCIPAL_INVESTIGATOR
Glostrup UH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glostrup University Hospital
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIRCAT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.